Urinary 2,5-hexanedione excretion in cryptogenic polyneuropathy compared to the general Swedish population

Background2,5-hexanedione (2,5-HD) is the main neurotoxic metabolite of methyl-n-butyl ketone (MBK) and n-hexane, and known to cause polyneuropathy. The aim of our study was to compare the urinary levels of 2,5-HD between cases with cryptogenic polyneuropathy and the general Swedish population, and to elucidate the role of certain external factors.MethodsMorning urine samples were collected from 114 cases with cryptogenic polyneuropathy (77 men and 37 women) and 227 referents (110 men and 117 women) randomly selected from the population registry. None had any current occupational exposure to n-hexane or MBK. The urine samples were analysed by a gas chromatographic method based on acidic hydrolysis.ResultsCases had statistically higher urinary levels of 2,5-HD (0.48 mg/L) than the general population (0.41 mg/L) and men higher excretion than women (0.48 mg/L and 0.38 mg/L, respectively). There was no difference in 2,5-HD levels between current smokers and non-smokers. Occupational exposure to xylene, alcohol consumption and ever exposed to general anaesthesia were associated with lower excretion in men while for occupational exposure to nitrous oxide in women higher excretion was seen. Higher excretion of 2,5 HD was inversely related to increasing age.ConclusionsSignificantly higher levels of urinary 2,5-HD were seen in men and cryptogenic polyneuropathy cases seemingly unexposed to n-hexane. Hypothetically, this might be due to either differences in metabolic patterns or some concealed exposure. The difference in means between cases and the general population is small and can therefore not allow any firm conclusions of the causality, however.

• Publication year

  2013

• Venue

  Journal of occupational medicine and toxicology

• Publication date

  2013-07-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.1186/1745-6673-8-21PMID 23898939PMCID 3733657
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Polymorphisms of GSTT1, GSTM1, and EPHX genotypes in patients with cryptogenic polyneuropathy: a case–control study

  2011cited by this paper
• N-hexane induced polyneuropathy: a clinical and electrophysiological follow up.

  2008cited by this paper
• Polyneuropathy induced by n-hexane intoxication in Taiwan.

  2008cited by this paper
• Occupational Determinants of Cryptogenic Polyneuropathy

  2006cited by this paper
• Association between metabolic gene polymorphisms and susceptibility to peripheral nerve damage in workers exposed to n-hexane: A preliminary study

  2006cited by this paper
• N-HEXANE NEUROPATHY DUE TO SHOEMAKING: REPORT OF FIVE CASES

  2005cited by this paper
• Cryptogenic polyneuropathy: clinical and neurophysiological findings

  2005cited by this paper
• Free and total 2,5-hexanedione in biological monitoring of workers exposed to n-hexane in the shoe industry.

  2003cited by this paper
• Poor metabolization of n-hexane in Parkinson's disease

  2003cited by this paper
• Experimental and Clinical Neurotoxicology, 2nd edition.

  2001cited by this paper
• Determination of urinary 2,5-hexanedione in the general Italian population

  1998cited by this paper
• Some immunological parameters in workers occupationally exposed to n-hexane

  1996cited by this paper
• Determination of 2,5-hexandione by high-performance liquid chromatography after derivatization with dansylhydrazine.

  1994cited by this paper
• Early diagnosis of n‐hexane–caused neuropathy

  1994cited by this paper
• [Quality control in a system for the biological surveillance of exposure to n-hexane].

  1993cited by this paper
• Biochemical and physiological aspects of 2,5-hexanedione: endogenous or exogenous product?

  1993cited by this paper
• Dose-dependent increase in 2,5-hexanedione in the urine of workers exposed to n-hexane

  1991cited by this paper
• An improved method of analysing 2,5-hexanedione in urine.

  1990cited by this paper
• The method of choice for the determination of 2,5-hexanedione as an indicator of occupational exposure to n-hexane

  1990cited by this paper
• [Gas chromatographic determination of 2,5-hexanedione in the urine].

  1986cited by this paper
• Detection of 2,5-hexanedione in the urine of persons not exposed to n-hexane

  1986cited by this paper
• Experimental and clinical neurotoxicology

  1980cited by this paper

• Mitophagy-dependent mitochondrial ROS mediates 2,5-hexanedione-induced NLRP3 inflammasome activation in BV2 microglia.

  2023cites this paper
• Towards Substitution of Hexane as Extraction Solvent of Food Products and Ingredients with No Regrets

  2022influential citation
• Levels of bioactive endogenous lipids and health-related quality of life in Chronic Idiopathic Axonal Polyneuropathy

  2022cites this paper
• The Role of Protein Adduction in Toxic Neuropathies of Exogenous and Endogenous Origin

  2021cites this paper
• Diabetes mellitus is associated with elevated urinary pyrrole markers of γ-diketones known to cause axonal neuropathy

  2020cites this paper
• The imbalance between dynamic and stable microtubules underlies neurodegeneration induced by 2,5-hexanedione.

  2020cites this paper
• 2,5-Hexanedione influences primordial follicular development in cultured neonatal mouse ovaries by interfering with the PI3K signaling pathway via miR-214-3p.

  2020cites this paper
• Urinary Levels of Free 2,5-Hexanedione in Italian Subjects Non-Occupationally Exposed to n-Hexane

  2019cites this paper
• Drug therapy for chronic idiopathic axonal polyneuropathy.

  2017cites this paper
• Determination of total urinary 2,5-hexanedione in the Chinese general population.

  2016cites this paper
• Registered cases of occupational n-hexane intoxication in Bucharest

  2015cites this paper